[Oxidative processes and lipid metabolism in the experimental induced Parkinsonian syndrome].
Ovsepian
L M
LM
Kazarian
G S
GS
Zakarian
A V
AV
L'vov
M V
MV
Melkonian
M M
MM
Zakharian
G V
GV
Akopdzhanian
A A
AA
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology; D000818:Animals; D004195:Disease Models, Animal; D050356:Lipid Metabolism; D015227:Lipid Peroxidation; D009498:Neurotoxins / Q000494:pharmacology; D010084:Oxidation-Reduction; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000378:metabolism*; D051381:Rats
D009498:Neurotoxins; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine